Unlock the Power of Genome Editing
カジノ シークレット 出 金 方法 Purity gRNA

  • 90%
    purity
    100 mer
  • 80+%
    purity
    130 mer
  • 200+ mer
    gRNA with
    world-class quality

Discover the power of gRNA in therapeutic applications with Sumitomo. As the leading Japanese GMP manufacturer,
we deliver top-notch gRNA up to 200 mer at unmatched purity levels. Our commitment to innovation enables us to develop exceptional analytical methods for your clinical needs.
Our standard manufacturing method also allows us to offer you seamless scale-up at short lead times.

CONTACT
FORM
REQUEST
DOCUMENTS

OUR STRENGTH

カジノ シークレット 出 金 方法

CHEMICALLY SYNTHESIZED gRNA
WITH
THE HIGHEST PURITY IN THE WORLD

With its unique technologies, カジノ シークレット 出 金 方法an offer you gRNAs with the highest purity in the world, e.g., 90% purity @100 mer and 80% @130 mer. As our technologies are based on solid-phase chemical synthesis, we can accommodate your needs to insert modified amidites wherever you want.

カジノ シークレット 出 金 方法

SEAMLESS AND
QUICK SCALE-UP

Long lead time is not needed. Sumitomo's standard manufacturing method for gRNAs ensures easy scaling up from laboratory to GMP production with just a single feasibility run.

カジノ シークレット 出 金 方法

STRONG ANALYTICAL CHEMISTRY

The longer your gRNA, the more difficult it is to accurately analyze the purity. For clinical needs, accurately determining the purity of your gRNA is of utmost importance. Sumitomo is proud of its high-resolution HPLC method for purity analysis. You have access to Sumitomo's standard analytical methods including high-resolution HPLC with a well-designed analytical control strategy.

ROBUST GMP COMPLIANCE AND TRACK RECORD

With 50 years of experience in GMP manufacturing of active pharmaceutical ingredients and their GMP intermediates, we have a strong record of FDA inspections . These high-quality standards are applied to gRNA manufacturing.

CASES

FACILITIES

facility image

Specialized in gRNA manufacturing

Our oligonucleotide manufacturing facility is specifically designed to produce high-purity gRNA and started its operations from August 2023 in Oita Prefecture, Japan. Leveraging our expertise in GMP, we ensure the delivery of high-quality products, seamlessly scaling up from laboratory to GMP production.

MORE

CONTACT US

We offer expertise in the full spectrum of manufacturing services for gRNAs for therapeutic use,
ranging from development through to clinical trials, full commercial launch and beyond.

We look forward to connecting with you and learning how we can help with your story.

NEWS

MORE